0001140361-23-038879.txt : 20230809 0001140361-23-038879.hdr.sgml : 20230809 20230809204112 ACCESSION NUMBER: 0001140361-23-038879 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230809 DATE AS OF CHANGE: 20230809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Amy CENTRAL INDEX KEY: 0001887865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 231156887 MAIL ADDRESS: STREET 1: 38 OUTLOOK ROAD CITY: SWAMPSCOTT STATE: MA ZIP: 01907 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 form4.xml X0508 4 2023-08-09 0001865494 IO Biotech, Inc. IOBT 0001887865 Sullivan Amy C/O IO BIOTECH, INC. OLE MAALOES VEJ 3 COPENHAGEN G7 2200 DENMARK true Chief Financial Officer false Common Stock 2023-08-09 4 A 0 49382 1.9 A 74382 D Warrants (Right to Buy) 2.47 2023-08-09 4 A 0 49382 0.125 A 2023-08-09 Common Stock 49382 49382 D These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023. /s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan 2023-08-09